Breaking News, Financial News

Financial Report: Sanofi 1Q

Genzyme sales up 31% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi   1Q Revenues: €8.8 billion (+12%)   1Q Earnings: €1.1 billion (flat)   Comments: Pharmaceutical sales were €7.5 billion, up 2% at Constant Exchange Rates (CER). Diabetes sales were €1.8 billion, down 3% reflecting expected pricing impact on Lantus in the U.S.Vaccines sales were €697 million, down 5% due to expected delay in Southern Hemisphere influenza campaign. Genzyme sales were €821 million, up 31% mainly driven by Aubagio.Animal Health sales were up 14% driven by NexGard....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters